Next-generation Sequencing Data Analysis Market (By Product: Services, NGS Commercial Software; By Workflow: Primary, Secondary, Tertiary; By Mode: In-house, Outsourced; By Read Length: Short Read Sequencing, Long Read Sequencing, Very Long Read Sequencing; By End-use: Academic Research, Clinical Research, Hospitals & Clinics, Pharma& Biotech Entities, Other Users) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20212030

The global Next-generation Sequencing Data Analysis market size is expected to be worth around US$ 5.72 billion by 2030, according to a new report by Vision Research Reports.

The global Next-generation Sequencing Data Analysis market size was valued at US$ 571.6 million in 2020 and is anticipated to grow at a CAGR of 16.2% during forecast period 2021 to 2030.

Next-generation Sequencing Data Analysis Market Size 2021 to 2030

Report Coverage

Report Scope Details
Market Size US$ 5.72 billion by 2030
Growth Rate CAGR of 16.2% From 2021 to 2030
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Product, Workflow, Mode, Read length, End-use
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Golden Helix, Inc.; Bio-Rad Laboratories, Inc.; SciGenom Labs Pvt. Ltd.; DNAnexus Inc.; Genuity Science; Fabric Genomics, Inc.; Congenica Ltd.; QIAGEN; DNASTAR, Inc.; Pacific Biosciences of California, Inc.; Eurofins Scientific; Partek Incorporated; Precigen Bioinformatics Germany GmbH; PierianDx; Agilent Technologies, Inc.; F. Hoffmann-La Roche Ltd.; Illumina, Inc.; Verily Life Science; Thermo Fisher Scientific, Inc.

Growth Factors

The easy availability of genomic and proteomic data is expected to create lucrative growth opportunities for this market during the forecast period. In addition, a decrease in the cost of sequencing is expected to increase the adoption rate of NGS, which, in turn, is likely to boost the market growth. The availability of tools such as Agilent’s HaloPlex capture system and Targeted Methyl-Seq platform from EpiGentek Group Inc. has helped in the determination of DNA methylation profiles in individual genomes.

The COVID-19 pandemic has accelerated the usage of NGS and created a massive requirement for NGS data analysis solutions. The NGS tools were able to generate a considerable amount of data for researchers to study and analyze the pathogenesis. The professionals from academia, industry and government have used sequencing and data analysis technology to assist in understanding the characteristics, processes, and phylogenetics ofSARS?CoV?2.

By Product Analysis

The services segment dominated the market with a revenue share of over 50.0% in 2020. Cost-effective NGS data analysis services are readily adopted by establishments that lack the required infrastructure for data management, analysis, and interpretation.

CLC Genomics Workbench offered by QIAGEN is one such data interpretation tools toolkit for epigenomics, genomics, metagenomics, and transcriptomics in one single program. Many companies are engaged in delivering products for data processing, i.e., data analysis tools that enable research entities to carry out projects using NGS.

Illumina, Genomatix, QIAGEN, and DNAStarare some of the companies that provide software and tools for the interpretation of generated data. Illumina and QIAGEN are the largest providers of software. Other key players such as ThermoFisher Scientific also offer commercial software for the analysis of NGS data. 

By Workflow Analysis

NGS tertiary data analysis dominated the market in 2020 with a revenue share of over 45.0%. Various annotation tools are utilized for NGS tertiary data analysis and companies are adopting strategic initiatives to expand the scope of these tools.

Secondary data analysis is anticipated to register the fastest CAGR over the forecast period. The rising application of whole-genome sequencing requires faster secondary analysis tools to fulfill the increasing demand. 

The field-programmable gate arrays are logic circuits that represent higher efficiency and speed as compared to conventional CPUs, especially for customized genomic analysis. On the other hand, cloud service providers including Amazon Web Services possess large data centers with large capacities to process a large number of samples simultaneously.

By Mode Analysis

In-house mode accounted for the largest revenue share of over 65.0% in 2020. The in-house mode includes companies that are involved in disease testing and diagnosis using NGS while conducting their analysis using available technology and software tools. Such companies operating in this segment are rapidly increasing.

The in-house analysis also allows quick incorporation of innovative scientific workflows into bioinformatics pipelines. These factors are responsible for the largest share of this segment and the segment is likely to maintain its lead during the forecast period. 

Outsourced mode is expected to register the fastest CAGR over the forecast period. Considering the cost advantages offered by outsourcing mode, companies such as SciBergprovide outsourced services. 

By Read Length Analysis

Short-read sequencing dominated the market in 2020 with a share of over 75.0% owing to the wide adoption and the availability of alignment tools and algorithms for short-read sequencing data. 

DRAGEN is a Bio-IT Platform that provides an ultra-rapid secondary analysis of sequencing data from whole genome, whole exome, and targeted sequencing workflows. 

The market shows lucrative opportunities for long and very long read sequencing segments. Guppy offered by Oxford Nanopore is a data processing toolkit that includes bioinformatic post-processing features and basecalling algorithms. 

By End-use Analysis

The academic research segment led the market in 2020 with a revenue share of over 50.0%. The growth can be attributed to a rise in the adoption of the workflows process in academic institutions. 

The University of Pittsburgh has established centers to perform sequencing, bioinformatics analysis, and high-performance computing to assist researchers with their ongoing academic research and projects.

The clinical research segment is expected to expand at the fastest growth rate from 2021 to 2028. Research initiatives for the development of in vitro tests using sequencing technology are expected to influence the growth of the clinical research segment.

PierianDx offers Clinical Genomicist Workspace software that provides clinical laboratories a more accurate and streamlined analysis, along with reporting and interpretation for personalized medicine programs.

By Regional Analysis

Europe held the largest revenue share of over 45.0%in 2020. This can be attributed to the presence of a significant number of key players, such as Illumina, Thermo Fisher Scientific, and Agilent Technologies, along with the presence of several organizations operating in this region that incorporates data analysis software.

Asia Pacific is expected to register the fastest growth rate over the forecast period. There has been significant progress in understanding the molecular basis of cancer with the use of sequencing technologies in Japan.

Key Players

  • Thermo Fisher Scientific, Inc.

  • QIAGEN

  • Illumina, Inc.

  • F. Hoffmann-La Roche Ltd.

  • Agilent Technologies, Inc.

  • Bio-Rad Laboratories, Inc.

  • PierianDx

  • Precigen Bioinformatics Germany GmbH

  • Partek Incorporated

  • Eurofins Scientific

  • Pacific Biosciences of California, Inc.

  • DNASTAR, Inc.

  • Congenica Ltd.

  • Fabric Genomics, Inc.

  • Genuity Science

  • DNAnexus Inc.

  • SciGenom Labs Pvt. Ltd.

  • Golden Helix, Inc.

  • Verily Life Science

Market Segmentation

  • By Product 

    • Services

    • NGS Commercial Software

      • Platform OS/UI

      • Analytical Software

        • QC/Pre-processing Tools

        • Alignment Tools & Software

          • DNA Seq Alignment

          • RNA Seq Alignment

          • Protein Seq Alignment

        • Others

  • By Workflow 

    • Primary

    • Secondary

      • Read Mapping

      • Variant Alignment & Variant Calling

    • Tertiary

      • Variant Annotation

      • Application Specific

        • Targeted Sequencing/ Gene Panel

        • Exome

        • RNA Seq

        • Whole Genome

        • Chip Seq

        • Others
  • By Mode

    • In-house

    • Outsourced

  • By Read Length

    • Short Read Sequencing

    • Long Read Sequencing

    • Very Long Read Sequencing

  • By End-use

    • Academic Research

    • Clinical Research

    • Hospitals & Clinics

    • Pharma& Biotech Entities

    • Other Users

  • Regional

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • France

      • U.K.

      • Italy

      • Spain

    • Asia Pacific

      • China

      • Japan

      • India

      • Australia

      • South Korea

    • Latin America

      • Brazil

      • Mexico

    • Middle East Africa (MEA)

      • South Africa

      • Saudi Arabia

The Next-generation Sequencing Data Analysis market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report provides size (in terms of volume and value) of Next-generation Sequencing Data Analysis market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global Next-generation Sequencing Data Analysis market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Next-generation Sequencing Data Analysis market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted Next-generation Sequencing Data Analysis market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

In terms of production side, this report researches the Next-generation Sequencing Data Analysis capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.

In terms of consumption side, this report focuses on the consumption of Next-generation Sequencing Data Analysis by regions (countries) and application.

Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Next-generation Sequencing Data Analysis market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Next-generation Sequencing Data Analysis market companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Next-generation Sequencing Data Analysis market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the Next-generation Sequencing Data Analysis industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

Next-generation Sequencing Data Analysis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Next-generation Sequencing Data Analysis market.

Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Next-generation Sequencing Data Analysis market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.

Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Next-generation Sequencing Data Analysis market. These factors have benefited the growth of the global market for Next-generation Sequencing Data Analysis. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.

New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Next-generation Sequencing Data Analysis. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).

In this study, the years considered to estimate the market size of Next-generation Sequencing Data Analysis are as follows:

  • History Year: 2017-2020
  • Base Year: 2021
  • Forecast Year 2021 to 2030

Reasons to Purchase this Report:


- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Next-generation Sequencing Data Analysis Market, By Product

7.1.  Next-generation Sequencing Data Analysis Market, by Product, 2021-2030

7.1.1.    Services

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    NGS Commercial Software

7.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Next-generation Sequencing Data Analysis Market, By Workflow

8.1.  Next-generation Sequencing Data Analysis Market, by Workflow, 2021-2030

8.1.1.    Primary

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Secondary

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Tertiary

8.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Next-generation Sequencing Data Analysis Market, By Mode

9.1.  Next-generation Sequencing Data Analysis Market, by Mode, 2021-2030

9.1.1.    In-house

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Outsourced

9.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Next-generation Sequencing Data Analysis Market, By Read Length

10.1.        Next-generation Sequencing Data Analysis Market, by Read Length, 2021-2030

10.1.1.  Short Read Sequencing

10.1.1.1.      Market Revenue and Forecast (2017-2030)

10.1.2.  Long Read Sequencing

10.1.2.1.      Market Revenue and Forecast (2017-2030)

10.1.3.  Very Long Read Sequencing

10.1.3.1.      Market Revenue and Forecast (2017-2030)

Chapter 11.      Global Next-generation Sequencing Data Analysis Market, By End-use

11.1.        Next-generation Sequencing Data Analysis Market, by End-use, 2021-2030

11.1.1.  Academic Research

11.1.1.1.      Market Revenue and Forecast (2017-2030)

11.1.2.  Clinical Research

11.1.2.1.      Market Revenue and Forecast (2017-2030)

11.1.3.  Hospitals & Clinics

11.1.3.1.      Market Revenue and Forecast (2017-2030)

11.1.4.  Pharma& Biotech Entities

11.1.4.1.      Market Revenue and Forecast (2017-2030)

Chapter 12.      Global Next-generation Sequencing Data Analysis  Market, Regional Estimates and Trend Forecast

12.1.        North America

12.1.1.  Market Revenue and Forecast, by Product (2017-2030)

12.1.2.  Market Revenue and Forecast, by Workflow (2017-2030)

12.1.3.  Market Revenue and Forecast, by Mode (2017-2030)

12.1.4.  Market Revenue and Forecast, by Read Length (2017-2030)

12.1.5.  Market Revenue and Forecast, by End-use (2017-2030)

12.1.6.  U.S.

12.1.6.1.      Market Revenue and Forecast, by Product (2017-2030)

12.1.6.2.      Market Revenue and Forecast, by Workflow (2017-2030)

12.1.6.3.      Market Revenue and Forecast, by Mode (2017-2030)

12.1.6.4.      Market Revenue and Forecast, by Read Length (2017-2030)

12.1.6.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.1.7.  Rest of North America

12.1.7.1.      Market Revenue and Forecast, by Product (2017-2030)

12.1.7.2.      Market Revenue and Forecast, by Workflow (2017-2030)

12.1.7.3.      Market Revenue and Forecast, by Mode (2017-2030)

12.1.7.4.      Market Revenue and Forecast, by Read Length (2017-2030)

12.1.7.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.2.        Europe

12.2.1.  Market Revenue and Forecast, by Product (2017-2030)

12.2.2.  Market Revenue and Forecast, by Workflow (2017-2030)

12.2.3.  Market Revenue and Forecast, by Mode (2017-2030)

12.2.4.  Market Revenue and Forecast, by Read Length (2017-2030)

12.2.5.  Market Revenue and Forecast, by End-use (2017-2030)

12.2.6.  UK

12.2.6.1.      Market Revenue and Forecast, by Product (2017-2030)

12.2.6.2.      Market Revenue and Forecast, by Workflow (2017-2030)

12.2.6.3.      Market Revenue and Forecast, by Mode (2017-2030)

12.2.6.4.      Market Revenue and Forecast, by Read Length (2017-2030)

12.2.6.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.2.7.  Germany

12.2.7.1.      Market Revenue and Forecast, by Product (2017-2030)

12.2.7.2.      Market Revenue and Forecast, by Workflow (2017-2030)

12.2.7.3.      Market Revenue and Forecast, by Mode (2017-2030)

12.2.7.4.      Market Revenue and Forecast, by Read Length (2017-2030)

12.2.7.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.2.8.  France

12.2.8.1.      Market Revenue and Forecast, by Product (2017-2030)

12.2.8.2.      Market Revenue and Forecast, by Workflow (2017-2030)

12.2.8.3.      Market Revenue and Forecast, by Mode (2017-2030)

12.2.8.4.      Market Revenue and Forecast, by Read Length (2017-2030)

12.2.8.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.2.9.  Rest of Europe

12.2.9.1.      Market Revenue and Forecast, by Product (2017-2030)

12.2.9.2.      Market Revenue and Forecast, by Workflow (2017-2030)

12.2.9.3.      Market Revenue and Forecast, by Mode (2017-2030)

12.2.9.4.      Market Revenue and Forecast, by Read Length (2017-2030)

12.2.9.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.3.        APAC

12.3.1.  Market Revenue and Forecast, by Product (2017-2030)

12.3.2.  Market Revenue and Forecast, by Workflow (2017-2030)

12.3.3.  Market Revenue and Forecast, by Mode (2017-2030)

12.3.4.  Market Revenue and Forecast, by Read Length (2017-2030)

12.3.5.  Market Revenue and Forecast, by End-use (2017-2030)

12.3.6.  India

12.3.6.1.      Market Revenue and Forecast, by Product (2017-2030)

12.3.6.2.      Market Revenue and Forecast, by Workflow (2017-2030)

12.3.6.3.      Market Revenue and Forecast, by Mode (2017-2030)

12.3.6.4.      Market Revenue and Forecast, by Read Length (2017-2030)

12.3.6.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.3.7.  China

12.3.7.1.      Market Revenue and Forecast, by Product (2017-2030)

12.3.7.2.      Market Revenue and Forecast, by Workflow (2017-2030)

12.3.7.3.      Market Revenue and Forecast, by Mode (2017-2030)

12.3.7.4.      Market Revenue and Forecast, by Read Length (2017-2030)

12.3.7.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.3.8.  Japan

12.3.8.1.      Market Revenue and Forecast, by Product (2017-2030)

12.3.8.2.      Market Revenue and Forecast, by Workflow (2017-2030)

12.3.8.3.      Market Revenue and Forecast, by Mode (2017-2030)

12.3.8.4.      Market Revenue and Forecast, by Read Length (2017-2030)

12.3.8.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.3.9.  Rest of APAC

12.3.9.1.      Market Revenue and Forecast, by Product (2017-2030)

12.3.9.2.      Market Revenue and Forecast, by Workflow (2017-2030)

12.3.9.3.      Market Revenue and Forecast, by Mode (2017-2030)

12.3.9.4.      Market Revenue and Forecast, by Read Length (2017-2030)

12.3.9.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.4.        MEA

12.4.1.  Market Revenue and Forecast, by Product (2017-2030)

12.4.2.  Market Revenue and Forecast, by Workflow (2017-2030)

12.4.3.  Market Revenue and Forecast, by Mode (2017-2030)

12.4.4.  Market Revenue and Forecast, by Read Length (2017-2030)

12.4.5.  Market Revenue and Forecast, by End-use (2017-2030)

12.4.6.  GCC

12.4.6.1.      Market Revenue and Forecast, by Product (2017-2030)

12.4.6.2.      Market Revenue and Forecast, by Workflow (2017-2030)

12.4.6.3.      Market Revenue and Forecast, by Mode (2017-2030)

12.4.6.4.      Market Revenue and Forecast, by Read Length (2017-2030)

12.4.6.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.4.7.  North Africa

12.4.7.1.      Market Revenue and Forecast, by Product (2017-2030)

12.4.7.2.      Market Revenue and Forecast, by Workflow (2017-2030)

12.4.7.3.      Market Revenue and Forecast, by Mode (2017-2030)

12.4.7.4.      Market Revenue and Forecast, by Read Length (2017-2030)

12.4.7.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.4.8.  South Africa

12.4.8.1.      Market Revenue and Forecast, by Product (2017-2030)

12.4.8.2.      Market Revenue and Forecast, by Workflow (2017-2030)

12.4.8.3.      Market Revenue and Forecast, by Mode (2017-2030)

12.4.8.4.      Market Revenue and Forecast, by Read Length (2017-2030)

12.4.8.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.4.9.  Rest of MEA

12.4.9.1.      Market Revenue and Forecast, by Product (2017-2030)

12.4.9.2.      Market Revenue and Forecast, by Workflow (2017-2030)

12.4.9.3.      Market Revenue and Forecast, by Mode (2017-2030)

12.4.9.4.      Market Revenue and Forecast, by Read Length (2017-2030)

12.4.9.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.5.        Latin America

12.5.1.  Market Revenue and Forecast, by Product (2017-2030)

12.5.2.  Market Revenue and Forecast, by Workflow (2017-2030)

12.5.3.  Market Revenue and Forecast, by Mode (2017-2030)

12.5.4.  Market Revenue and Forecast, by Read Length (2017-2030)

12.5.5.  Market Revenue and Forecast, by End-use (2017-2030)

12.5.6.  Brazil

12.5.6.1.      Market Revenue and Forecast, by Product (2017-2030)

12.5.6.2.      Market Revenue and Forecast, by Workflow (2017-2030)

12.5.6.3.      Market Revenue and Forecast, by Mode (2017-2030)

12.5.6.4.      Market Revenue and Forecast, by Read Length (2017-2030)

12.5.6.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.5.7.  Rest of LATAM

12.5.7.1.      Market Revenue and Forecast, by Product (2017-2030)

12.5.7.2.      Market Revenue and Forecast, by Workflow (2017-2030)

12.5.7.3.      Market Revenue and Forecast, by Mode (2017-2030)

12.5.7.4.      Market Revenue and Forecast, by Read Length (2017-2030)

12.5.7.5.      Market Revenue and Forecast, by End-use (2017-2030)

Chapter 13.  Company Profiles

13.1.              Thermo Fisher Scientific, Inc.

13.1.1.  Company Overview

13.1.2.  Product Offerings

13.1.3.  Financial Performance

13.1.4.  Recent Initiatives

13.2.              QIAGEN

13.2.1.  Company Overview

13.2.2.  Product Offerings

13.2.3.  Financial Performance

13.2.4.  Recent Initiatives

13.3.              Illumina, Inc.

13.3.1.  Company Overview

13.3.2.  Product Offerings

13.3.3.  Financial Performance

13.3.4.  Recent Initiatives

13.4.              F. Hoffmann-La Roche Ltd.

13.4.1.  Company Overview

13.4.2.  Product Offerings

13.4.3.  Financial Performance

13.4.4.  Recent Initiatives

13.5.              Agilent Technologies, Inc.

13.5.1.  Company Overview

13.5.2.  Product Offerings

13.5.3.  Financial Performance

13.5.4.  Recent Initiatives

13.6.              Bio-Rad Laboratories, Inc.

13.6.1.  Company Overview

13.6.2.  Product Offerings

13.6.3.  Financial Performance

13.6.4.  Recent Initiatives

13.7.              PierianDx

13.7.1.  Company Overview

13.7.2.  Product Offerings

13.7.3.  Financial Performance

13.7.4.  Recent Initiatives

13.8.              Precigen Bioinformatics Germany GmbH

13.8.1.  Company Overview

13.8.2.  Product Offerings

13.8.3.  Financial Performance

13.8.4.  Recent Initiatives

13.9.              Partek Incorporated

13.9.1.  Company Overview

13.9.2.  Product Offerings

13.9.3.  Financial Performance

13.9.4.  Recent Initiatives

13.10.           Eurofins Scientific

13.10.1.               Company Overview

13.10.2.               Product Offerings

13.10.3.               Financial Performance

13.10.4.               Recent Initiatives

Chapter 14.  Research Methodology

14.1.              Primary Research

14.2.              Secondary Research

14.3.              Assumptions

Chapter 15.  Appendix

15.1.              About Us

Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers